Based on the previous data about these targets in the treatment of patients with ESCC, the present study attempted to assess the status of MSI phenotype and HER2 expression and mutation in the PI3K pathway in ESCC in Iranian patients. Here, ERBB2 is linked to esophageal squamous cell carcinoma.